Last $3.91 USD
Change Today 0.00 / 0.00%
Volume 62.0K
ROSG On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brian A. Markison

Chairman, Observer To Board of Directors and Member of Nominating & Corporate Governance Committee, Rosetta Genomics, Ltd.
AgeTotal Calculated CompensationThis person is connected to 59 board members in 13 different organizations across 12 different industries.

See Board Relationships
55--

Background*

Mr. Brian A. Markison has been an Healthcare Industry Executive of Avista Capital Holdings, L.P. since September 10, 2012. Mr. Markison served as Chief Executive Officer and the President of Fougera Pharmaceuticals Inc. since August 1, 2011. He joined King Pharmaceuticals LLC (King Pharmaceuticals Inc). in March 2004 and served as its President since July 2004, Chief Executive Officer since May 2004 and also its Chairman since May 2007. He served as the Chief Operating ...

Read Full Background

Corporate Headquarters*

10 Plaut Street
Rehovot, -- 76706

Israel

Phone: 972 73 222 0700
Fax: 972 73 222 0701

Board Members Memberships*

Director
Chief Executive Officer, President and Director
Director
2004-Present
Lead Director, Chairman of Compensation Committee, Member of Research & Development Committee and Member of Governance & Nominating Committee
2004-N/A
Chairman, Chief Executive Officer, and President
2008-Present
Director
2011-Present
Chairman, Observer To Board of Directors and Member of Nominating & Corporate Governance Committee
2011-Present
Independent Director and Chairman of Compensation Committee
2012-Present
Non-Executive Chairman of the Board
2012-Present
Director
2012-Present
Non-Executive Chairman
2013-Present
Director and Member of Compensation Committee
2013-Present
Executive Chairman

Education*

BS 1982
Iona College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROSG:US $3.91 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$380.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROSETTA GENOMICS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.